MGNX was aquarterly gainer,rising+433.64%.Expect Uptrend reversa
Macrogenics (MGNX, $28.87) was one of top quarterly gainers, jumping +433.64% to $28.87 per share. Tickeron A.I.dvisor analyzed 379 stocks in the Biotechnology Industry over the last three months, and discovered that 352 of them (92.98%) charted an Uptrend while 27 of them (7.02%) trended down. Tickeron A.I.dvisor found 287 similar cases when MGNX's price went up 15% within three months. In 208 out of those 287 cases, MGNX's price went down during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend reversal for MGNX are 72%.
The higher Bollinger Band was broken -- a price fall is expected as the ticker heads toward the middle band, which invites the trader to consider selling or shorting the ticker, or exploring put options. In 37 of 41 cases where MGNX's price broke its higher Bollinger Band, its price dropped further during the following month. The odds of a continued Downtrend are 90%.
The higher Bollinger Band was broken -- a price fall is expected as the ticker heads toward the middle band, which invites the trader to consider selling or shorting the ticker, or exploring put options. In 37 of 41 cases where MGNX's price broke its higher Bollinger Band, its price dropped further during the following month. The odds of a continued Downtrend are 90%.
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.